ARCHIVES

Memorial’s Scher Warns FDA About Flaws In Provenge Data, Urges Not To Approve.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

New NCI Director Proposes $9 Million Community Cancer Centers Program.

September 8, 2006

Cancer Prevention: Review Group’s Report Urges Integration Of Prevention with all NCI Research

June 27, 1997

Dalton To Head Moffitt Cancer Center; HHS Appoints Gerberding CDC Director

July 12, 2002

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

March 23, 1984

CyberKnife Delivers 100 Percent PFS at 18.3 Month Followup

January 27, 2012

Study Attributes Drop In Breast Cancer Incidence To Decline In Hormone Replacement.

December 15, 2006